Clinical Trial: Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789041) titled 'Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge' on Sept. 19, 2025.

Brief Summary: Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure

Study Start Date: Aug. 12, 2025

Study Type: INTERVENTIONAL

Condition: BPH (Benign Prostatic Hyperplasia) BPH With Symptomatic Lower Urinary Tract Symptoms

Intervention: DEVICE: PuraStat hydrogel and the syringe

PuraStat device is FDA-approved for other uses, such as gastrointestinal endoscopy and ENT (ear, nose, throat) procedures. Its use in this study for u...